In glioblastoma, c-Met-mediated EC plasticity induces mesenchymal transformation to promote EC proliferation and migration, resulting in aberrant vasculature formation and chemoresistance to multiple therapies (Table 1)19. The gene discussed is MET; the disease is glioblastoma.